Compounds > losartan

losartan and thromboplastin

losartan has been researched along with thromboplastin in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	7 (70.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Kasahara, T; Kawano, H; Kimura, S; Kitamura, H; Kunieda, Y; Masuda, H; Nakagawa, K; Nakagawa, M; Nakahara, Y; Nishimura, H; Sawada, S; Sugano, T; Tsuji, H; Yano, S; Yoshizumi, M	1
Camera, M; Di Santo, A; Lorenzet, R; Napoleone, E; Tremoli, E	1
Dechend, R; Gulba, DC; Haller, H; Homuth, V; Juepner, A; Kreuzer, J; Luft, FC; Mackman, N; Park, JK; Theuer, J; Wallukat, G	1
Kaikita, K; Kajiwara, I; Miyamoto, S; Nakamura, S; Ogawa, H; Sakamoto, T; Shimomura, H; Soejima, H; Suefuji, H; Takazoe, K; Yoshimura, M	1
Chen, FP; He, MX; He, SL; He, XF; Xie, QZ	1
Beevers, DG; Chung, NA; Lip, G	1
Chen, F; He, M; He, S; He, X; Xie, Q	1
Grabowski, EF; Ingelfinger, JR; Kushak, RI; Nestoridi, E; Tsukurov, O	1
Kudoh, T; Matsui, K; Ogawa, H; Sakamoto, K; Sakamoto, T	1
Ardiana, M; Harsoyo, PM; Hermawan, HO; Muhammad, AR; Sufiyah, IM; Suryawan, IGR; Zaini, BSI	1

Trials

3 trial(s) available for losartan and thromboplastin

Article	Year
Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction. The American journal of cardiology, 2001, Jun-15, Volume: 87, Issue:12 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Coagulation Factors; Double-Blind Method; Enalapril; Female; Fibrinolysis; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Thrombolytic Therapy; Thromboplastin; Tissue Plasminogen Activator	2001
Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension. Blood pressure, 2004, Volume: 13, Issue:3 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diuretics; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Neovascularization, Pathologic; Sodium Chloride Symporter Inhibitors; Thromboplastin; von Willebrand Factor	2004
Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:6 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Hypertension; Losartan; Male; Middle Aged; Pilot Projects; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Thromboembolism; Thromboplastin; Time Factors; Treatment Outcome	2014

Other Studies

7 other study(ies) available for losartan and thromboplastin

Article	Year
The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thrombosis and haemostasis, 1999, Volume: 82, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta; Blood Coagulation; Endothelium, Vascular; Fibrinolysis; Gene Expression Regulation; Imidazoles; Lipoproteins; Losartan; Plasminogen Activator Inhibitor 1; Pyridines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thromboplastin; Tissue Plasminogen Activator	1999
Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circulation research, 2000, Feb-04, Volume: 86, Issue:2 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Blood Coagulation; Captopril; Cell Nucleus; Dimerization; Endotoxins; Gene Expression; Humans; In Vitro Techniques; Losartan; Monocytes; NF-kappa B; Proto-Oncogene Proteins c-rel; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thromboplastin	2000
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation, 2000, May-23, Volume: 101, Issue:20 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Cells, Cultured; CHO Cells; Coronary Vessels; Cricetinae; Enzyme Activation; Female; Humans; Losartan; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Placenta; Pre-Eclampsia; Pregnancy; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; Thromboplastin; Transcription Factor AP-1; Transfection	2000
[Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes and its mechanisms]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2003, Volume: 24, Issue:9 Topics: Angiotensin II; Gene Expression Regulation; Genistein; Humans; Losartan; Monocytes; NF-kappa B; Protein Kinase C; Receptor, Angiotensin, Type 1; RNA, Messenger; Staurosporine; Thromboplastin	2003
Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thrombosis research, 2006, Volume: 117, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Coagulation; Blood Coagulation Tests; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Profiling; Humans; I-kappa B Proteins; Leukocytes, Mononuclear; Losartan; Monocytes; NF-kappa B; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Thromboplastin	2006
Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Endothelium, Vascular; Humans; Imidazoles; Kidney Glomerulus; Losartan; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Shiga Toxin 1; Thromboplastin; Tumor Necrosis Factor-alpha; Up-Regulation	2008
Perindopril and losartan attenuate pro-coagulation factors in human adipocytes exposed to SARS-CoV-2 spike protein. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2023, Volume: 74, Issue:3 Topics: Adipocytes; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Cardiovascular Agents; COVID-19; Humans; Losartan; Male; Obesity; Perindopril; Plasminogen Activator Inhibitor 1; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thromboplastin	2023